SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. - Grippin AJ; Marconi C; Copling S; Li N; Braun C; Woody C; Young E; Gupta P; Wang M; Wu A; Jeong SD; Soni D; et al. (Nature, 2025)